Owp Drug Patent Portfolio
Owp owns 1 orange book drug protected by 2 US patents Given below is the list of Owp's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11596634 | Lamotrigine Oral Liquid Suspension And Use Thereof | 29 May, 2040 | Active |
| US11612566 | Lamotrigine Oral Liquid Suspension And Use Thereof | 29 May, 2040 | Active |
Latest Legal Activities on Owp's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Owp.
| Activity | Date | Patent Number |
|---|---|---|
| ||
| Patent Issue Date Used in PTA Calculation | 28 Mar, 2023 | US11612566 |
| Recordation of Patent Grant Mailed | 28 Mar, 2023 | US11612566 |
| Issue Notification Mailed | 08 Mar, 2023 | US11612566 |
| Patent Issue Date Used in PTA Calculation | 07 Mar, 2023 | US11596634 |
| Recordation of Patent Grant Mailed | 07 Mar, 2023 | US11596634 |
| Dispatch to FDC | 24 Feb, 2023 | US11612566 |
| Application Is Considered Ready for Issue | 24 Feb, 2023 | US11612566 |
| Issue Fee Payment Received | 20 Feb, 2023 | US11612566 |
| Issue Notification Mailed | 15 Feb, 2023 | US11596634 |
| Application Is Considered Ready for Issue | 02 Feb, 2023 | US11596634 |
| Dispatch to FDC | 02 Feb, 2023 | US11596634 |
| Issue Fee Payment Received | 01 Feb, 2023 | US11596634 |
| Issue Fee Payment Verified | 01 Feb, 2023 | US11596634 |
| Mail Notice of Allowance | 21 Nov, 2022 | US11612566 |
| Issue Fee Payment Verified | 21 Nov, 2022 | US11612566 |
Owp's Family Patents
Owp Drug List
Given below is the complete list of Owp's drugs and the patents protecting them.
1. Subvenite
Subvenite is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11596634 | Lamotrigine Oral Liquid Suspension And Use Thereof |
29 May, 2040
(14 years from now)
| Active |
| US11612566 | Lamotrigine Oral Liquid Suspension And Use Thereof |
29 May, 2040
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Subvenite's drug page